siRNA delivery by a transferrin-associated lipid-based vector: A non-viral strategy to mediate gene silencing

Journal of Gene Medicine

Volumn 9, Issue 3, 2007, Pages 170-183

  Cardoso, A L C ^a,b   Simoes S ^a,c   de Almeida, L P ^a,c   Pelisek, J ^d   Culmsee, C ^d   Wagner, E ^d   Pedroso de Lima, M C ^a,b  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c UNIVERSITY OF COIMBRA   (Portugal)

^d UNIVERSITY OF MUNICH   (Germany)

Author keywords

c Jun; Cationic liposomes; Gene silencing; Glutamate toxicity; Serum protection; siRNA delivery; Transferrin

Indexed keywords

1,2 DIOLEOYL 3 TRIMETHYLAMMONIOPROPANE; LIPOSOME; PLASMID DNA; PROTEIN C JUN; SMALL INTERFERING RNA; TRANSFERRIN;

ARTICLE; CANCER CELL; CELL CULTURE; CELL LINE; CELL SELECTION; COMPLEX FORMATION; CONFOCAL MICROSCOPY; DRUG FORMULATION; ENZYMATIC DEGRADATION; FUNCTIONAL GENOMICS; GEL ELECTROPHORESIS; GENE EXPRESSION; GENE SILENCING; GENE TARGETING; GENE TRANSFER; HUMAN; HUMAN CELL; IMMUNOASSAY; IMMUNOBLOTTING; INTERNALIZATION; NONVIRAL GENE DELIVERY SYSTEM; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN TRANSPORT; REAL TIME POLYMERASE CHAIN REACTION; RNA ANALYSIS; RNA INTERFERENCE;

CATIONS; CELL LINE, TUMOR; FATTY ACIDS, MONOUNSATURATED; FLUORESCENCE; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENES, REPORTER; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIPIDS; LIPOSOMES; NEOPLASMS; QUATERNARY AMMONIUM COMPOUNDS; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSFERRIN;

EID: 34047102911     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.1006     Document Type: Article

References (59)

1. Caplen NJ. Gene therapy progress and prospects. Downregulating gene expression: the impact of RNA interference. Gene Ther 2004; 11: 1241-1248.
2. Fire A, et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998; 391: 806-811.
3. Napoli C, Lemieux C, Jorgensen R. Introduction of a chimeric chalcone synthase gene into petunia results in reversible co-suppression of homologous genes in trans. Plant Cell 1990; 2: 279-289.
4. Hannon GJ, Rossi JJ. Unlocking the potential of the human genome with RNA interference. Nature 2004; 431: 371-378.
5. Gitlin L, Karelsky S, Andino R. Short interfering RNA confers intracellular antiviral immunity in human cells. Nature 2002; 418:430-434.
6. Jacque JM, Triques Y, Stevenson M. Modulation of HIV-1 replication by RNA interference. Nature 2002; 418: 435-438.
7. Lee NS, et al. Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nat Biotechnol 2002; 20:500-505.
8. Brummelkamp TR, Bemards R, Agami R. Stable suppression of tumorigenicity by virus-mediated RNA interference. Cancer Cell 2002; 2:243-247.
9. Scherr M, et al. Specific inhibition of bcr-abl gene expression by small interfering RNA. Blood 2003; 101: 1566-1569.
10. Wilda M, Fuchs U, Wossmann W, Borkhardt A. Killing of leukemic cells with a BCR/ABL fusion gene by RNA interference (RNAi). Oncogene 2002; 21: 5716-5724.
11. Wohlbold L, et al. Inhibition of bcr-abl gene expression by small interfering RNA sensitizes for imatinib mesylate (STI571). Blood 2003;102:2236-2239.
12. Song E, et al. RNA interference targeting Fas protects mice from fulminant hepatitis. Nat Med 2003; 9: 347-351.
13. Zender L, et al. Caspase 8 small interfering RNA prevents acute liver failure in mice. Proc Natl Acad Sci USA 2003; 100: 7797-7802.
14. Ding H, et al. Selective silencing by RNAi of a dominant allele that causes amyotrophic lateral sclerosis. Aging Cell 2003; 2: 209-217.
15. Gonzalez-Alegre P, Miller VM, Davidson BL, Paulson HL. Toward therapy for DYT1 dystonia: allele-specific silencing of mutant TorsinA. Ann Neurol 2003; 53: 781-787.
16. Miller VM, et al. Allele-specific silencing of dominant disease genes. Proc Natl Acad Sci U S A 2003; 100: 7195-7200.
17. Bernstein E, Caudy AA, Hammond SM, Hannon GJ. Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 2001; 409: 363-366.
18. Martinez J, et al. Single-stranded antisense siRNAs guide target RNA cleavage in RNAL Cell 2002; 110: 563-574.
19. Zamore PD, Tuschl T, Sharp PA, Bartel Dp. RNAi double-stranded RNA directs the ATP-dependent qeavage of mRNA at 21 to 23 nucleotide intervals. Cell 2000; 101: 25-33.
20. Brand S. Antisense-RNA regulation and RNA interference. Biochim Biophys Acta 2002; 1575: 15-25.
21. Calegari F, et al. Tissue-specific RNA interference in postimplantation mouse embryos with endoribonuclease-prepared short interfering RNA. Proc Natl Acad Sci U S A 2002; 99:14236-14240.
22. Matsuda T, Cepko CL. Electroporation and RNA interference in the rodent retina in vivo and in vitro. Proc Nad Acad Sci U S A 2004; 101: 16-22.
23. Spagnou S, Miller AD, Keller M. Lipidic carriers of siRNA: differences in the formulation, cellular uptake, and delivery with plasmid DNA. Biochemistry 2004; 43: 13348-13356.
24. Behle MA. Progress towards in vivo use of siRNAs. Mol Ther 2006; 13: 644-670.
25. Frantz S. Safety concerns raised over RNA interference. Nat Rev Drug Discov 2006; 5: 528-529.
26. Marques JT, Williams BR. Activation of the mammalian immune system by siRNAs. Nat Biotechnol 2005; 23: 1399-1405.
27. Sioud M. Innate sensing of self and non-self RNAs by Toll-like receptors. Trends Mol Med 2006; 12: 167-176.
28. Sledz CA, et al. Activation of the interferon system by short-interfering RNAs. Nat Cell Biol 2003; 5: 834-839.
29. da Cruz MT, et al. Tf-lipoplex-mediated NGF gene transfer to the CNS: neuronal protection and recovery in an excitotoxic model of brain injury. Gene Ther 2005; 12: 1242-1252.
30. da Cruz MT, Simoes S, de Lima MC. Improving lipoplex-mediated gene transfer into C6 glioma cells and primary neurons. Exp Neurol 2004; 187: 65-75.
31. Simoes S, et al. Cationic liposomes for gene delivery. Expert Opin Drug Deliv 2005; 2: 237-254.
32. Simoes S, et al. Mechanisms of gene transfer mediated by lipoplexes associated with targeting ligands or pH-sensitive peptides. Gene Ther 1999; 6: 1798-1807.
33. da Cruz MT, et al. Kinetic analysis of the initial steps involved in lipoplex-cell interactions: effect of various factors that influence transfection activity. Biochim Biophys Acta 2001; 1510: 136-151.
34. Crook K, Stevenson BJ, Dubouchet M, Porteous DJ. Inclusion of cholesterol in DOTAP transfection complexes increases the delivery of DNA to cells in vitro in the presence of serum. Gene Ther 1998; 5: 137-143.
35. Hirsch-Lerner D, et al. Effect of "helper lipid" on lipoplex electrostatics. Biochim Biophys Acta 2005; 1714: 71-84.
36. Simberg D, Weisman S, Talmon Y, Barenholz Y. DOTAP (and other cationic lipids): chemistry, biophysics, and transfection. Crit Rev Ther Drug Carrier Syst 2004; 21: 257-317.
37. Simberg D, Weiss A, Barenholz Y. Reversible mode of binding of serum proteins to DOTAP/cholesterol Lipoplexes: a possible explanation for intravenous lipofection efficiency. Hum Gene Ther 2005; 16: 1087-1096.
38. Simoes S, et al. Transfection of human macrophages by lipoplexes via the combined use of transferrin and pH-sensitive peptides. J Leukoc Biol 1999; 65: 270-279.
39. Li H, Qian ZM. Transferrin/transferrin receptor-mediated drug delivery. Med Res Rev 2002; 22: 225-250.
40. Shi N, Boado RJ, Pardridge WM. Receptor-mediated gene targeting to tissues in vivo following intravenous administration of pegylated immunoliposomes. Pharm Res 2001; 18: 1091-1095.
41. Shi N, et al. Brain-specific expression of an exogenous gene after i.v. administration. Proc Natl Acad Sci USA 2001; 98: 12754-12759.
42. Hatakeyama H, et al. Factors governing the in vivo tissue uptake of transferrin-coupled polyethylene glycol liposomes in vivo. Int J Pharm 2004; 281: 25-33.
43. Simoes S, et al. Gene delivery by negatively charged ternary complexes of DNA, cationic liposomes and transferrin or fusigenic peptides. Gene Ther 1998; 5: 955-964.
44. Tros de Ilarduya C, Duzgunes N. Efficient gene transfer by transferrin lipoplexes in the presence of serum. Biochim Biophys Acta 2000; 1463: 333-342.
45. Pedroso de Lima MC, et al. Cationic lipid-DNA complexes in gene delivery: from biophysics to biological applications. Adv Drug Deliv Rev 2001; 47: 277-294.
46. Raivich G, Behrens A. Role of the AP-1 transcription factor c-Jun in developing, adult and injured brain. Prog Neurobiol 2006; 78: 347-363.
47. Campbell MJ. Lipofection reagents prepared by a simple ethanol injection technique. Biotechniques 1995; 18: 1027-1032.
48. Tan S, Wood M, Maher P. Oxidative stress induces a form of programmed cell death with characteristics of both apoptosis and necrosis in neuronal cells. J Neurochem 1998; 71: 95-105.
49. Konopka K, Pretzer E, Felgner PL, Duzgunes N. Human immunodeficiency virus type-1 (HIV-1) infection increases the sensitivity of macrophages and THP-1 cells to cytotoxicity by cationic liposomes. Biochim Biophys Acta 1996; 1312: 186-196.
50. Ambros V. The functions of animal microRNAs. Nature 2004; 431:350-355.
51. Lippman Z, Martienssen R. The role of RNA interference in heterochromatic silencing. Nature 2004; 431: 364-370.
52. Mittal V. Improving the efficiency of RNA interference in mammals. Nat Rev Genet 2004; 5: 355-365.
53. Kariko K, Buckstein M, Ni H, Weissman D. Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. Immunity 2005; 23:165-175.
54. Judge AD, et al. Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA. Nat Biotechnol 2005; 23: 457-462.
55. Bridge AJ, et al. Induction of an interferon response by RNAi vectors in mammalian cells. Nat Genet 2003; 34: 263-264.
56. Ma Z, et al. Cationic lipids enhanq siRNA-mediated interferon response in mice. Biochem Biophys Res Commun 2005; 330: 755-759.
57. Agrawal S, Kandimalla ER. Role of Toll-like receptors in antisense and siRNA [corrected]. Nat Biotechnol 2004; 22: 1533-1537.
58. Yoo JW, Hong SW, Kim S, Lee DK. Inflammatory cytokine induction by siRNAs is cell type- and transfection reagent-specific. Biochem Biophys Res Commun 2006; 347: 1053-1058.
59. Behrens A, Sibilia M, Wagner EF. Amino-terminal phosphorylation of c-Jun regulates stress-induced apoptosis and cellular proliferation. Nat Genet 1999; 21: 326-329.